Newsroom | 13104 results
Sorted by: Latest
-
Two HSS Rheumatologists Receive Prestigious National Career Honors at Annual American College of Rheumatology Meeting
ORLANDO, Fla.--(BUSINESS WIRE)--The American College of Rheumatology (ACR) and the Lupus Foundation of America (LFA) have honored two rheumatologists at Hospital for Special Surgery (HSS) with prestigious career awards recognizing their transformative contributions to lupus research, education and patient care. The ceremonies took place during the ACR Convergence conference in Orlando, Florida, from November 6 to 11. Mary K. Crow, MD, received the Evelyn V. Hess Award from the LFA, which honors...
-
CyberKnife® Inventor John Adler, MD, Wins 2026 Thomas J. Fogarty Innovation Prize
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--CyberKnife inventor John Adler, MD, wins the 2026 Fogarty Prize for frameless, image-guided radiosurgery, transforming care for more than 1M patients...
-
Surgery Partners and HealthSpan Partners Announce Amended Merger Agreement, Following Receipt of Unsolicited Proposal
BRENTWOOD, Tenn. & CINCINNATI--(BUSINESS WIRE)--Surgery Partners, Inc. (NASDAQ: SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, and HealthSpan Partners, a contractual affiliate and supporting organization of U.S.-based Bon Secours Mercy Health (“BSMH”), today announced an amendment to its previously announced merger agreement. The amendment follows Surgery Partners’ receipt of an unsolicited competing proposal from a third party. The amend...
-
Orthofix Reports Third Quarter 2026 Results and Revises Full-Year 2026 Guidance
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported financial results for the third quarter ended September 30, 2026, and revised its full-year 2026 net sales and non-GAAP adjusted EBITDA guidance. Unless otherwise noted, pro forma results exclude the impact of the discontinued M6™ product lines. Third Quarter 2026 Highlights Total reported net sales of $207.9 million, representing an increase of 1% on a reported b...
-
HealthTrust Explores OR Economics and the Future of Supply Chain Leadership at Becker’s 2026 CEO + CFO Roundtable
NASHVILLE, Tenn.--(BUSINESS WIRE)--HealthTrust Performance Group™ (HealthTrust) participated in the 2026 Becker’s CEO + CFO Roundtable held November 2–5 at the Hyatt Regency Chicago, where two executive panel discussions focused on critical challenges facing healthcare organizations: operating room economics and the future of supply chain leadership. The four-day conference brought together more than 1,500 executive-level attendees and more than 450 hospital and health system speakers, creating...
-
Clínica de Estética Shonan Nomeada para a Lista dos “Melhores Hospitais e Clínicas do Mundo para Turismo Médico 2027” da Newsweek
IRVINE, Califórnia--(BUSINESS WIRE)--A SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“A Empresa” ou “SBC Medical”), uma Organização de Serviços Médicos (MSO) que oferece suporte de gestão em uma ampla gama de áreas da saúde, anunciou hoje que a Clínica de Estética Shonan, uma das marcas de clínicas que apoia, foi nomeada para a lista dos “Melhores Hospitais e Clínicas do Mundo para Turismo Médico 2027”, um ranking internacional apresentado pela Newsweek em parceria com a Statista. A cl...
-
HSS Study Highlights Potential for CAR T-Cell Therapy to Transform Lupus Treatment
ORLANDO, Fla.--(BUSINESS WIRE)--A type of cellular therapy originally developed to treat cancer is showing promise as a potential treatment for people with difficult-to-treat lupus, according to a new study from researchers at Hospital for Special Surgery (HSS). Known as chimeric antigen receptor (CAR) T-cell therapy, the approach is increasingly being investigated for the treatment of systemic lupus erythematosus (SLE). The study, CAR T-Cell Therapy in SLE: A Pooled Analysis, was presented tod...
-
bioAffinity Technologies Reports Third Quarter 2026 Results and Continued Momentum in CyPath® Lung Commercialization
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies reports third quarter 2026 results, continued momentum in CyPath Lung commercialization...
-
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced the award of inducement grants. On November 5, 2026, as an inducement material to acceptance of employment with CareDx, 21 new employees were awarded restricted stock units (RSUs) for an aggregate of 33,375 shares of common stock. The RSUs will vest over four years, with 25% of the RSUs vesting on the first anniver...
-
اختيار Shonan Beauty Clinic ضمن قائمة "أفضل المستشفيات والعيادات في العالم للسياحة العلاجية لعام 2027" الصادرة عن مجلة Newsweek
إيرفين، كاليفورنيا--(BUSINESS WIRE)--أعلنت SBC Medical Group Holdings Incorporated (المدرجة في بورصة ناسداك بالرمز: SBC) (يُشار إليها فيما يلي باسم "الشركة" أو "SBC Medical")، وهي مؤسسة متخصصة في إدارة الخدمات الطبية (MSO) وتقديم الدعم الإداري لمجموعة واسعة من قطاعات الرعاية الصحية، اليوم، عن اختيار Shonan Beauty Clinic، إحدى العلامات التجارية للعيادات التي تقدم لها الدعم، ضمن قائمة "أفضل المستشفيات والعيادات في العالم للسياحة العلاجية لعام 2027"، وهو تصنيف دولي تصدره مجلة Newsweek بالشراكة مع ش...